Related Experiment Video

Updated: Oct 19, 2025

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.0K

Critical Needs in Advancing Shigella Vaccines for Global Health

Calman A MacLennan1, Kawsar R Talaat2, Robert W Kaminski3

  • 1Bill & Melinda Gates Foundation, London, United Kingdom.

The Journal of Infectious Diseases
|September 24, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ShigellaCHIMLMICsglobal healthvaccines

More Related Videos

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.2K
A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

9.1K

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
517
Vaccinations01:51

Vaccinations

Overview
46.6K